PE47099A1 - Compuestos de 2-imidazolinilaminoindazol utiles como agonistas de alfa-2 adrenoreceptores - Google Patents

Compuestos de 2-imidazolinilaminoindazol utiles como agonistas de alfa-2 adrenoreceptores

Info

Publication number
PE47099A1
PE47099A1 PE1997001067A PE00106797A PE47099A1 PE 47099 A1 PE47099 A1 PE 47099A1 PE 1997001067 A PE1997001067 A PE 1997001067A PE 00106797 A PE00106797 A PE 00106797A PE 47099 A1 PE47099 A1 PE 47099A1
Authority
PE
Peru
Prior art keywords
alkyl
formula
compounds
alpha
imidazolinylaminindazol
Prior art date
Application number
PE1997001067A
Other languages
English (en)
Spanish (es)
Inventor
William Lee Seibel
Jeffrey Joseph Ares
Russell James Sheldon
Raymond Todd Henry
Thomas Lee Cupps
Sophie Eva Bogdan
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE47099A1 publication Critical patent/PE47099A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
PE1997001067A 1996-11-25 1997-11-25 Compuestos de 2-imidazolinilaminoindazol utiles como agonistas de alfa-2 adrenoreceptores PE47099A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
PE47099A1 true PE47099A1 (es) 1999-06-12

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997001067A PE47099A1 (es) 1996-11-25 1997-11-25 Compuestos de 2-imidazolinilaminoindazol utiles como agonistas de alfa-2 adrenoreceptores

Country Status (20)

Country Link
EP (1) EP0944620A1 (xx)
JP (1) JP2001506599A (xx)
KR (1) KR20000069104A (xx)
CN (1) CN1244864A (xx)
AR (1) AR010643A1 (xx)
AU (1) AU5433998A (xx)
BR (1) BR9713535A (xx)
CA (1) CA2272644A1 (xx)
CO (1) CO4910166A1 (xx)
CZ (1) CZ183999A3 (xx)
HU (1) HUP9904660A3 (xx)
ID (1) ID22676A (xx)
IL (1) IL130067A0 (xx)
NO (1) NO992502L (xx)
NZ (1) NZ335882A (xx)
PE (1) PE47099A1 (xx)
SK (1) SK69699A3 (xx)
TR (1) TR199901542T2 (xx)
WO (1) WO1998023609A1 (xx)
ZA (1) ZA9710576B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
JPWO2009084695A1 (ja) 2007-12-28 2011-05-19 カルナバイオサイエンス株式会社 ２−アミノキナゾリン誘導体
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
CN1137755A (zh) * 1993-12-17 1996-12-11 普罗克特和甘保尔公司 用作α-2肾上腺素能受体兴奋剂的6-(2-咪唑啉基氨基)喹喔啉化合物

Also Published As

Publication number Publication date
NO992502L (no) 1999-07-26
NZ335882A (en) 2000-12-22
AU5433998A (en) 1998-06-22
TR199901542T2 (xx) 2000-01-21
BR9713535A (pt) 2000-03-21
CO4910166A1 (es) 2000-04-24
ID22676A (id) 1999-12-09
ZA9710576B (en) 1998-09-16
CA2272644A1 (en) 1998-06-04
HUP9904660A3 (en) 2002-02-28
JP2001506599A (ja) 2001-05-22
SK69699A3 (en) 2000-06-12
IL130067A0 (en) 2000-02-29
HUP9904660A2 (hu) 2000-06-28
AR010643A1 (es) 2000-06-28
KR20000069104A (ko) 2000-11-25
CZ183999A3 (cs) 1999-11-17
EP0944620A1 (en) 1999-09-29
CN1244864A (zh) 2000-02-16
WO1998023609A1 (en) 1998-06-04
NO992502D0 (no) 1999-05-25

Similar Documents

Publication Publication Date Title
PE16299A1 (es) Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoreceptores
PE1998A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
ES2044878T3 (es) Un proceso para la preparacion de derivados de benzimidazol.
PE20001600A1 (es) Derivados de 1,4-diazabiciclo (3.3.2) nonan-4-carboxilatos y carboxamidas, su preparacion y su aplicacion en terapeutica
DE59803845D1 (de) Sulfinsäurederivate und deren herstellung und verwendung
PE20040840A1 (es) Derivados de 4-oxoquinolina como inhibidores de la integrasa del vih
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
PE16399A1 (es) Compuestos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
PT939627E (pt) Pentafluorobenzenossulfonamidas e analogos
PE20010685A1 (es) Composicion que comprende un polipeptido antagonista del receptor de interleuquina 1 y una diarilsulfonilurea como inhibidor del procesamiento y la liberacion de il-1
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
PE107999A1 (es) Derivados 3-amidinoanilina, inhibidores del factor x de coagulacion de la sangre activado e intermediarios de los mismos
AR013477A1 (es) Prostaglandinas de tetrahidro sustituido c16-20 aromatico utiles como agonistas de fp.
PE20081781A1 (es) Agonistas de adrenoreceptores alfa2c funcionalmente selectivos
ES2172580T3 (es) 1,3-oxatiolanos sustituidos con propiedades antiviricas.
PE20040698A1 (es) Derivados de isoindolina
PE16599A1 (es) Compuestos de (2-imidazolinilamino) benzoxazol utiles como agonistas de alfa-2 adrenoreceptores
PE106299A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)-1h-indol
PE20020144A1 (es) Derivados de pleuromutilinas como agentes antibacterianos
PE20010127A1 (es) Suspension de ziprasidona
AR016551A1 (es) Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos
PE47099A1 (es) Compuestos de 2-imidazolinilaminoindazol utiles como agonistas de alfa-2 adrenoreceptores
PT775118E (pt) Derivados de benzimidazole com actividade dopaminergica
AR024840A1 (es) Compuestos de 5ht1 para terapia antidepresiva; composiciones farmaceuticas y su uso en la preparacion de medicamentos.

Legal Events

Date Code Title Description
FX Voluntary withdrawal